article
Adherence to Antiretroviral Medications for HIV Pre-Exposure Prophylaxis
Linda J. Koeniga b✉, Cynthia M. Lylesc, Dawn K. Smithc
- aDivision of HIV/AIDS Prevention, National Center for HIV, Viral Hepatitis, STD and TB Prevention, CDC, Atlanta, Georgia 30333, USA. lkoenig@cdc.gov
- bDivision of HIV/AIDS Prevention, National Center for HIV, Viral Hepatitis, STD and TB Prevention, CDC, Atlanta, Georgia 30333, USA
- cDivision of HIV/AIDS Prevention, National Center for HIV, Viral Hepatitis, STD and TB Prevention, CDC, Atlanta, Georgia
- ✉Corresponding author
Looking for the full paper…
Papers open inside SciRah from the original publisher or repository; SciRah never hosts them.
Abstract
No abstract is available from our sources. Use “Read paper” to view it.
TL;DRFindings from adherence analyses rom PrEP clinical trials and the antiretroviral treatent adherence literature are summarized. (Semantic Scholar)